docetaxel anhydrous has been researched along with metribolone in 1 studies
Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (metribolone) | Trials (metribolone) | Recent Studies (post-2010) (metribolone) |
---|---|---|---|---|---|
12,110 | 3,216 | 6,920 | 744 | 0 | 92 |
Protein | Taxonomy | docetaxel anhydrous (IC50) | metribolone (IC50) |
---|---|---|---|
Sex hormone-binding globulin | Rattus norvegicus (Norway rat) | 0.0037 | |
Androgen receptor | Homo sapiens (human) | 0.004 | |
Androgen receptor | Rattus norvegicus (Norway rat) | 0.002 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deng, Y; Karnes, RJ; Konety, BR; Mukhtar, H; Parray, A; Saleem, M; Siddique, HR; Tarapore, RS; Wang, L | 1 |
1 other study(ies) available for docetaxel anhydrous and metribolone
Article | Year |
---|---|
BMI1 polycomb group protein acts as a master switch for growth and death of tumor cells: regulates TCF4-transcriptional factor-induced BCL2 signaling.
Topics: Animals; Antineoplastic Agents; Apoptosis; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cell Proliferation; Cellular Senescence; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Male; Metribolone; Mice; Mice, Nude; Neoplasm Transplantation; Polycomb Repressive Complex 1; Promoter Regions, Genetic; Prostate; Prostatic Neoplasms; Protein Binding; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Taxoids; Testosterone Congeners; Transcription Factor 4; Transcription Factors | 2013 |